This week, the secondary copper market showed a divergent pattern under the dual influence of improving macro expectations ...

This week, the secondary copper rod market struggled to operate under the dual pressures of volatile copper prices and policy ...

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...

Randomized trial data support the use of either TNF or IL-17 inhibitors to treat axial spondyloarthritis, based on patient ...

Elon Musk’s artificial intelligence company xAI has launched Grokipedia 0.1, positioning it as a direct rival to Wikipedia, ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

Narcolepsy is not associated with increased risk for mortality of any type, even among patients with a higher prevalence of ...

Background Smoke-free and aerosol-free households (SAFHs) reduce exposure to secondhand smoke and aerosol and support ...

Background The minimally important difference (MID) for frailty variation associated with adverse outcomes remains unknown in ...

Positive results from the global PREVAIL phase III trial showed that gefurulimab met its primary ... all secondary endpoints, including change from baseline in Quantitative Myasthenia Gravis (QMG) ...

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...